chrisvoncsefalvay/vaers-outcomes huggingface dataset:
havent gotten  2nd jab. Its been over a month.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (havent gotten  2nd jab. Its been over a month.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (havent gotten  2nd jab. Its been over a month.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (havent gotten  2nd jab. Its been over a month.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient have concerned that can he suffer from blood clots that form after 2nd shot   No concomitant medications were reported  No treatment information was provided   Reporter did not allow further contact
Patient reported that she is suffering from memory loss and hair loss, she was also hallucinating and had to have someone come in and help her get dressed and was in the bed for 3 weeks
Information has been received from a 76 year old female with drug reaction to sulfa and a history of mastectomy and reconstructive surgery (in 1998) who in May 2008, was vaccinated with ZOSTAVAX (Merck) (lot # not reported). Concomitant therapy included ADVAIR and blood pressure pills. On 03-JUL-2010 the patient broke out with shingles. The patient also reported a sore throat along with blisters and bumps all along her arm. Unspecified medical attention was sought and there was no laboratory test performed. Additional information has been requested.
Swelling 3" x 3" warm to touch. Benadryl 25mg. POQ6 PRN Advil PRN.
hives/lesions all over her body; hives/lesions all over her body; severe allergic reaction to the second Pfizer booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (005570).  A female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (DOSE NUMBER UNKNOWN (BOOSTER), MANUFACTURER UNKNOWN; 1st booster), for Covid-19 immunization. The following information was reported: URTICARIA (non-serious), SKIN LESION (non-serious), outcome "not recovered" and all described as "hives/lesions all over her body"; HYPERSENSITIVITY (non-serious), outcome "not recovered", described as "severe allergic reaction to the second Pfizer booster". The events "hives/lesions all over her body" and "severe allergic reaction to the second pfizer booster" required physician office visit.  Additional information: It was reported that she broke out in hives/lesions all over her body and continued to have the hives/lesions, which were not going away. She had seen a dermatologist who told her it was a reaction to the second booster. It's been 4-5 months. No sign of it going away. She continued to see the dermatologist. Wanted to know if there was anything that can be done.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
BELLS PALSY; This spontaneous report received from a consumer via social media (J and J Corporate) concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported, 01 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced Bell's Palsy. As per the consumer, "Maybe you can explain why my cousin after the COVID shot got bells palsy but was deemed safe by every single commercial on TV and by fact checkers, you have to give every single possible side effects on every other medication out there but not one of you promoting the jab had to mention anything". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of bells palsy was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20221201872-Bells palsy. The event has an unknown/unclear temporal relationship, and is labeled. There is no information on any other factors potentially associated with the event. Therefore, this event is considered consistent with vaccine administration.
The patient began to experience heart palpitations about 10 minutes after receiving the Pfizer COVID vaccine (first dose). The HR was checked and marked to be 110bpm. The pt then began to experience tingling at the injection site as well as in the lower bilateral extremities. The pt was escorted to the holding area to lie down on the stretcher. VS checked (139/89 BP, HR 95, Temp 98.4, O2Sat 100%.). Dr in the ACC was called to assess and observe the patient. No further recommendation for treatment was given. Patient was observed for a total of thirty minutes. HR remained within normal limits and pt was cleared to be discharged to home safely. Pt ambulated to personal vehicle with nurse escort.
On Tuesday 10/30/18 she woke up and she felt like her balance was off, had to hold on to furniture in order to walk. On Wednesday 10/31/18 it was worse when she woke up. I as the pharmacist advised her to call her doctor right away because she said she couldn't feel her legs and she couldn't stand. She had an appointment with her doctor that afternoon and was unable to walk and she could not feel from her knees down. The doctor immediately recognized the symptoms and sent her to the hospital right away. They directly admitted her. She spent 9 days in the hospital. They diagnosed her with Guillain-Barre Syndrome within 24 hours of being in the hospital. She had no reflexes from her knees down. She received 5 plasmapheresis treatments every other day while she was in the hospital. Her doctor said that the Guillain-Barre syndrome was from the flu shot not the Shingrix since it was a few days before. She still is doing PT two days per week and the bottoms of her feet are still numb.
This is a spontaneous report obtained from a contactable nurse through a Pfizer sales representative. This nurse reported for two patients. This is the 1st of two reports. An 18-year-old female patient of an unspecified race/ethnicity received TRUMENBA (Lot # R94916, Expiry date  01Jan2019) intramuscular at 0.5 ml, single in the arm on 22Feb2017 for immunisation. The patient medical history and concomitant medications were not reported.  On an unspecified date in Feb2017, the patient experienced nausea, chills, lethargic, arm soreness of the arm that the product was injected into. The patient did not experience any fever. The outcome of the events was recovered on unknown date.
I received my second dose of BEXSERO Meningococcal B Vaccine on the morning of March 3, 2017. Of course, as with the first dose, I felt extreme muscle pain following the vaccination. I also felt very fatigued and tired in the evening so I went to bed early that night (as with the first dose). However, I do not remember having such a bad injection site reaction. Three days later (today, March 4) I have a lot of redness at the site, it is very tender to the touch, and also a little bit itchy. I am hoping it will go away on its own so I don't have to go back into the doctor.
My left arm started hurting on Friday  March 19 and is still hurting. I can not sleep on the left side since getting the vaccine. It hurts to move the arm different ways. Many times, I have to lay flat to  get relief from the pain. I don't have alot of strength in my left arm since getting the vaccine. I consulted the school nurse about my effects and she stated it could be an inflamed nerve.
Woke up at 3 am with violent vertigo episodes. Also experienced chills and cold symptoms, but I had experienced those side effects after the first two covid vaccines. The vertigo was unexpected and had never happened before. After two weeks, the symptoms are milder, but I am still experiencing vertigo.
He got the vaccine, he's been having fever but did not take it and feels he is still running fever.  He is having pain in his left shoulder on the backside and has heartburn.   He did take some Ibuprofen yesterday, but nothing else, not even for the fever.   No problems with the area around the injection site.
pt reports one hour post vaccination, episodes of diaphoresis. Resolved W/I 5 minutes. V/S taken at 1030 WNL BP - 121/85 SpO2 - 98% HR - 90 RR 18
The patient registered for the vaccine with a DOB of (unlisted).  She was vaccinated before realizing her real DOB is (unlisted).  She experienced no adverse reaction
Muscle achiness since he received shot on 5/13/10 (minor achiness).
the needle went in and pierced out through the patient's skin; administered the MMR II vaccine epidermally, rather than subcutaneously; This spontaneous report has been received from the patient's mother referring to a 1 year old male patient. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided.  On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) intradermally (reported as epidermally), rather than subcutaneously for prophylaxis (dose detail, anatomical location, batch/lot # and expiration date were not reported) (incorrect route of product administration). The needle went in and pierced out through the patient's skin.  The outcome of the events was unknown.  No causality assessment was provided.
Muscle aching, chills, 102-degree fever.  Then increasing pain in the lower left abdominal area over 3-4 hours while lying in bed with the fever, etc.  Finally, around 5 pm, the pain was unbearable -- 10+ on a scale of 1-10.  I was unable to walk without stabbing pain.  I called friends to help me get to the hospital.  I was admitted to the emergency room at Hospital around 6 pm.  I spent that night and two more days in the hospital.  A low-grade infection was found and two intravenous antibiotics were administered -- Cipro and Flagyl.
Patients representative notified pharmacy today to cancel patients second appointment as the patient had died this morning due to a staff infection in hospital.  Representative did state they did not believe it was related to vaccination as patient has been having difficult time with underlying conditions (pulmonary fibrosis and atrial fibrillation).
Received Tdap vaccination on the same day approximately 4 hours before COVID vaccine on the opposite arm. Experienced soreness and muscle aches radiating from injection location for three days. Slight rash on arms and sore hips on and off over next two weeks. Tested negative for COVID using PCR test 6 days after vaccination. 12 days after vaccination, tested positive for COVID. Started experiencing headache on day 10 and muscles ached all over body. Peak of body aches experienced on day 13. No congestion, no cough, no sneezing, no runny nose, no sore throat, no loss of smell or taste, no difficulty breathing, no heavy chest.
patient was given the 1st injection on 25Jul2023. The next injection that the patient received was on 18Aug2023, a three week gap with no reported adverse event; Initial information was received on 29-Aug-2023 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves an unknown age female patient to whom the 1st injection of rabies (HDC) vaccine [Imovax rabies] on 25jul2023, the next injection was given on 18aug2023, a three week gap with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a 1 ml, twice dose of suspect rabies (HDC) vaccine (Powder and solvent for suspension for injection) (lot number, expiry date, strength, was unknown) via unknown route in unknown administration site for Immunization and patient was given the 1st injection on 25jul2023, the next injection that the patient received was on 18aug2023, a three week gap with no reported adverse event (inappropriate schedule of product administration) (unknown latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
20NOV95 mom reported 3 days to 1 wk p/vax pt had h/a;went to walk in clinic to see MD 15FEB95;dx w/migraines & treated for pain;cont to c/o head hurting & pain med was changes;went to ER 19FEB95 adm w/viral meningitis;pt exp sore throat
her husband tested positive on 29MAR 2021 and she was direct exposed; Diarrhea; fluid in ears; tested positive for Covid; tested positive for Covid; runny nose and sneezing; runny nose and sneezing; itchy ears and itchy throat; itchy ears and itchy throat; trouble breathing at night; This is a spontaneous report received from a contactable consumer (patient). A 45-Year-Old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EP3302) via an unspecified route of administration in left arm on 13Jan2021 at around 14:00-15:00 as single dose for COVID-19 immunization. Patient medical history included high blood pressure from 6-7 years ago and still ongoing. Concomitant medications were not reported. Patient received historical vaccination as first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), formulation: Solution for injection, Lot number: EH9899, via an unspecified route of administration in left arm on 23Dec2020 10:30 AM at single dose for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. on 3Apr2021, she started having allergy symptoms like a runny nose and sneezing, itchy ears and itchy throat and had trouble breathing at night with clinical outcome of not recovered. She states that the doctor told her she had fluid in both of her ears on 5Apr2021 with outcome of event not recovered. she has diarrhea on 06Apr2021, with outcome of event not recovered. She reported that not even two months later, she has tested positive for COVID-19 on 05APR2021. She states that her husband tested positive on 29MAR2021 and she was direct exposed (exposure to SARS-COV-2) due to work she had to quarantine for 14 days, states her daughter tested positive two days after her husband, states neither of them had the vaccine. The patient did not receive any treatment for the events. The clinical outcomes of event not recovered.  No follow-up attempts are possible. No further information is expected.
pt recvd MMR vax 14MAR91 & on 17MAR92 devel a fever, vomiting, & wheezing; 4 days later devel a diffuse papular rash on face, trunk & extremities;
Patient admitted to hospital on 11/4/2021  Tested positive for COVID in October 14 (reported by the daughter) Retested during current hospitalization, tested positive COVID19PCR 11/5/2021 Complaint of dizziness, vomiting, ataxia that started on 11/3/2021 no cough, no shortness of breath, on room air and not hypoxic
Severe pain in arm at site of shot. Fatigue. Whole body soreness. Feverish without fever. Loss of appetite   Headache
Patient when into store 10/08 with a lot of pain, redness, and fluid build up around her elbow area on her right arm - the arm she was given Pneumovax in. She reported fever-like symptoms and feeling very badly the night of the shot, followed by "severe" pain in the arm. The injection site looked completely normal, no redness or swelling at all. The arm was certainly inflamed and red around the elbow area and it did not seem like a normal reaction to Rph or floater that was here. She was still reporting pain on the "distressing level" today. I referred her up to the walk in clinic, and she said she'd go straight there.    The physician at urgent care stated The reaction should resolve itself.  I spoke with patient today and she stated the swelling had gone down and the area was starting to bruise.  She already had an appointment with her primary physician scheduled for today and she will discuss the reaction with them later today.
By september 3 , 2021 , I got vaccinated against COVID with the first dose at 7:30pm at 2 in the morning on september 4 2021  I got up with a strong tachycardia, chills, chest pain, headache and stomach pain which in the course of the week and even months did not slow down my heart rate.. visti cardiologist which diagnosed me with miocarditis..visit neurologist for headache problems and hallucination, severe panic attack..being a person who before the vaccine was healthy and did not seem at all
About 5-10 minutes after vaccine, pt was flushed and appeared tremulous for a few seconds. Resp WNL 21, pulse 90, BP 92/58 responsive. Drowsy, "lethargic, pale, bad headache", ambulatory, went to MD after injection, having a "brainn fx test" on Wednesday.
received a full dose of Moderna COVID-19 vaccine after 3 doses of Pfizer COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a full dose of Moderna COVID-19 vaccine after 3 doses of Pfizer COVID-19 vaccine) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Pfizer COVID-19 vaccine (the first one on 06-Mar-2021 and the second one on 03-Apr-2021 and the third on 20-Aug-2021.) from 06-Mar-2021 to 20-Aug-2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine.    On 10-Dec-2021, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a full dose of Moderna COVID-19 vaccine after 3 doses of Pfizer COVID-19 vaccine). On 10-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a full dose of Moderna COVID-19 vaccine after 3 doses of Pfizer COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
24MAY96 phone call from parent pt has fever of 103 & a very swollen, red lt arm w/pain into the neck;pt referred to urgent care & prescribed APAP & warm packs
tested positive for covid-19; tested positive for covid-19; he had a cold; Coughing; runny nose; congestion; This is a spontaneous report from a contactable consumer (Patient's wife). A 68-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3246), intramuscular in Right arm on 07Jan2021 at 08:30-08:35 at single dose for covid-19 immunisation. Medical history was reported as none. There were no concomitant medications. The patient had symptoms and was tested positive for covid-19 on 22Jan2021 10:20. On 12Jan2021 04:00, the patient had coughing, runny nose, congestion and thought he had a cold. The patient was scheduled to have his second dose on 28Jan2021, and the reporter wanted to know if the patient should get it or not. The outcome of the event COVID-19 was unknown, of other events was recovering.
Redness at injection site still continuing 11 days after injection, a little itchy, getting a little bigger each day
Headache; Vaccine was drawn up into a plastic syringe and left out for 3 hours; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Vaccine was drawn up into a plastic syringe and left out for 3 hours) and HEADACHE (Headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event reported).   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Vaccine was drawn up into a plastic syringe and left out for 3 hours). On an unknown date, the patient experienced HEADACHE (Headache). On 04-Feb-2021, PRODUCT ADMINISTRATION ERROR (Vaccine was drawn up into a plastic syringe and left out for 3 hours) had resolved. At the time of the report, HEADACHE (Headache) outcome was unknown.            Very limited information regarding this event/s has been provided at this time.  Further information has been requested.   This case was linked to MOD-2021-065749 (Patient Link).; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
HORRIBLE CHILLS for 4 straight hours from 7pm-11pm, body ache, head ache, upset stomach, and sore left arm
hospitalization; Second dose not given within 21-42 day internval; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of HOSPITALISATION (hospitalization) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL, METOLAZONE, LEVOTHYROXINE, OMEPRAZOLE, ALPRAZOLAM, AMIODARONE and IRON for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HOSPITALISATION (hospitalization) (seriousness criterion hospitalization) and PRODUCT DOSE OMISSION ISSUE (Second dose not given within 21-42 day internval). At the time of the report, HOSPITALISATION (hospitalization) and PRODUCT DOSE OMISSION ISSUE (Second dose not given within 21-42 day internval) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered HOSPITALISATION (hospitalization) to be not related. No further causality assessment was provided for PRODUCT DOSE OMISSION ISSUE (Second dose not given within 21-42 day internval).    Very limited information regarding this events has been provided at this time. Further information has been requested. This report also refers to a case of product dose omission issue for mRNA-1273 with no associated AEs.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. This report also refers to a case of product dose omission issue for mRNA-1273 with no associated AEs.
Patient stated Chest pains, back pains, difficulty walking and talking, inflamed lungs,  found Left vascular atelectasis in lung while in hospital, referred to PCP.  Patient said that it was hurts to talk, lungs burning, chest tightening, upper back sensitive to touch. CPAP helps with pressure in chest and back.